Biochimie 1995-01-01

Induction of apoptotic cell death by DNA topoisomerase II inhibitors.

C Negri, R Bernardi, M Donzelli, A I Scovassi

Index: Biochimie 77 , 893-899, (1995)

Full Text: HTML

Abstract

We have analyzed the interference of antitumoral drugs acting through the inhibition of DNA topoisomerase II on the human HeLa cell metabolism. Different compounds characterized by a diverse mechanism of action have been used, namely m-amsacrine, an intercalative drug, etoposide, which does not intercalate DNA, and suramin, which exerts its effect through an unknown mechanism. In HeLa cells treated with increasing doses of these drugs, we have examined cell viability and DNA synthesis capacity, and we have evaluated topoisomerase II activity. Cellular morphology and DNA integrity have been studied in order to characterize the mechanism of cell death. The results we have obtained clearly indicate that topoisomerase II poisons induce cell death by apoptosis. These observations suggest a role of the inhibition of topoisomerase II activity in the apoptotic program.

Related Compounds

  • acridinyl anisidid...

Related Articles:

Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells.

2014-01-01

[Nat. Commun. 5 , 4825, (2014)]

Induction of chromosomal aberrations (unstable and stable) by inhibitors of topoisomerase II, m-AMSA and VP16, using conventional Giemsa staining and chromosome painting techniques.

1998-01-01

[Mutagenesis 13 , 39-43, (1998)]

Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

1984-03-01

[Proc. Natl. Acad. Sci. U. S. A. 81 , 1361-1365, (1984)]

The potential of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide to circumvent three multidrug-resistance phenotypes in vitro.

1997-01-01

[Cancer Chemother. Pharmacol. 39 , 424-430, (1997)]

Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine.

1996-01-01

[Environ. Mol. Mutagen. 27 , 255, (1996)]

More Articles...